NCT04159974 2024-05-09
RICE
University of Cologne
Phase 2 Unknown
Clinical Trials
16 trialsNCT02037048 2024-01-08
FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma
Case Comprehensive Cancer Center
Phase 2 Unknown
NCT05690958 2023-04-05
ACCEPT-survey
Radboud University Medical Center
Unknown
NCT05745857 2023-02-27
SLURP
University Medical Center Groningen
Phase 2 Unknown
NCT03399071 2023-02-21
ICONIC
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT03995017 2023-02-01
RiME
University of Kansas Medical Center
Phase 1/2 Unknown
NCT04818476 2021-03-26
Outcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising in Barrett's Esophagus
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Unknown
NCT03474341 2020-11-16
PRIDE
UMC Utrecht
Unknown
NCT04194463 2020-03-12
ChemoFit
Newcastle-upon-Tyne Hospitals NHS Trust
Phase NA Unknown
NCT03626610 2018-08-13
Pre-EMPT
Guy's and St Thomas' NHS Foundation Trust
Phase NA Unknown
NCT02583087 2017-08-28
ESTEBAN
Hôpital Cochin
Unknown
NCT00987857 2017-08-22
Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus
Gloucestershire Hospitals NHS Foundation Trust
Phase NA Unknown
NCT02628665 2015-12-11
Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer
The First Affiliated Hospital of Henan University of Science and Technology
Phase 3 Unknown
NCT02464930 2015-06-08
Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia
Midwest Veterans' Biomedical Research Foundation
Unknown
NCT01776346 2013-01-28
BPR
Massachusetts General Hospital
Unknown
NCT00509561 2012-12-18
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
Wales Cancer Trials Unit
Phase 2/3 Unknown